4.4 Article

Exploring the causal association of rheumatoid arthritis with atrial fibrillation: a Mendelian randomization study

期刊

CLINICAL RHEUMATOLOGY
卷 -, 期 -, 页码 -

出版社

SPRINGER LONDON LTD
DOI: 10.1007/s10067-023-06804-4

关键词

Atrial fibrillation (AF); Genome-wide association study (GWAS); Hereditary susceptibility; Mendelian randomization (MR); Rheumatoid arthritis (RA)

向作者/读者索取更多资源

This study provides genetic evidence for the causal association between rheumatoid arthritis (RA) and atrial fibrillation (AF) using multiple Mendelian randomization (MR) methods. RA patients are genetically more susceptible to AF. This study sheds light on the underlying mechanisms of RA-induced AF and inspires future research on the relationship between RA and AF.
BackgroundIt has been proved that rheumatoid arthritis (RA) patients have high incidence of atrial fibrillation (AF). Nevertheless, whether they have causal relevance is uncertain. This study aimed to explore and verify the authenticity of causal relationship between RA and AF using Mendelian randomization (MR).MethodsThe genome-wide association study (GWAS) summary data from Biobank Japan Project (BBJ) (RA, 4199 cases and 208,254 controls) were regarded as exposure data and the GWAS data from European Bio-informatics Institute database (EBI) (AF, 15,979 cases and 102,776 controls) as outcome data. The causal effect was appraised by the inverse variance weighted (IVW) method, MR-Egger regression, and weighted median estimator. MR-robust adjusted profile score (MR-RAPS) method was delivered to examine the robustness of causal relationship and MR Pleiotropy Residual Sum and Outlier (MR-PRESSO) method to control horizontal (directional) pleiotropy.ResultsThe results indicated that RA increased the risk of AF (IVW, the odds ratio (OR) = 1.060; 95% confidence interval (CI), 1.028 to 1.092; p = 1.411 x 10-4; weighted median, OR = 1.046, 95% CI, 1.002 to 1.093, p = 0.047). The MR analysis also showed this causal effect through all four IVW methods with various statistical algorithms. Both MR-RAPS and MR-PRESSO supported the causality of RA and AF. Also, the MR-PRESSO result indicated the absence of apparent pleiotropy.ConclusionThere is a causal association between RA and AF. RA patients are genetically more vulnerable to AF. This study may contribute to further exploring early clinical prevention and fundamental mechanism of AF in patients with RA.Key Points center dot We provided some genetic evidence for the causal link between rheumatoid arthritis (RA) and atrial fibrillation (AF) with multiple Mendelian randomization (MR) methods.center dot RA patients were genetically more vulnerable to AF.center dot This study partly shed light on latent fundamental mechanisms underlying RA-induced AF and inspired future studies on RA-AF relationship.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Emodin alleviates myocardial ischemia/reperfusion injury by inhibiting gasdermin D-mediated pyroptosis in cardiomyocytes

Bozhi Ye, Xudong Chen, Shanshan Dai, Jibo Han, Xiaohe Liang, Shuang Lin, Xueli Cai, Zhouqing Huang, Weijian Huang

DRUG DESIGN DEVELOPMENT AND THERAPY (2019)

Article Physiology

Aerobic Exercise Ameliorates Myocardial Inflammation, Fibrosis and Apoptosis in High-Fat-Diet Rats by Inhibiting P2X7 Purinergic Receptors

Xudong Chen, Haiyan Li, Kangwei Wang, Xiaohe Liang, Weiqi Wang, Xiaokang Hu, Zhouqing Huang, Yonghua Wang

FRONTIERS IN PHYSIOLOGY (2019)

Article Cell Biology

Trimetazidine affects pyroptosis by targeting GSDMD in myocardial ischemia/reperfusion injury

Xudong Chen, Shuang Lin, Shanshan Dai, Jibo Han, Peiren Shan, Weiqi Wang, Zhouqing Huang, Bozhi Ye, Weijian Huang

Summary: Trimetazidine can protect cardiomyocytes from ischemia/reperfusion injury by inhibiting inflammation. This research is of great significance for the development of alternative treatments for myocardial I/R injury.

INFLAMMATION RESEARCH (2022)

Article Plant Sciences

Inhibition of TAK1/TAB2 complex formation by costunolide attenuates obesity cardiomyopathy via the NF-κB signaling pathway

Bozhi Ye, Xudong Chen, Yanghao Chen, Wante Lin, Diyun Xu, Zimin Fang, Nipon Chattipakorn, Weijian Huang, Xu Wang, Gaojun Wu, Guang Liang

Summary: This study demonstrates that Costunolide (Cos) can improve obesity cardiomyopathy by inhibiting inflammation. Through molecular docking, we confirmed that Cos targets TAK1 and inhibits NF-kappa B pathway activation by blocking the formation of the TAK1/TAB2 complex, thereby reducing inflammatory cytokine release and improving myocardial inflammation. Moreover, Cos effectively reduces cardiac hypertrophy and fibrosis caused by obesity, leading to improved cardiac function against obesity cardiomyopathy.

PHYTOMEDICINE (2023)

Review Cardiac & Cardiovascular Systems

Association of serum uric acid with prognosis in patients with myocardial infarction: an update systematic review and meta-analysis

Lei Huang, Jiacheng Rong, Cheng Fang, Xudong Chen, Chaokun Hong

Summary: This study aimed to examine the occurrence of immediate and long-term adverse outcomes in individuals with elevated levels of uric acid following a diagnosis of myocardial infarction (MI). The study included a large sample size of 225,600 MI patients and found that patients diagnosed with hyperuricemia had significantly increased rates of short-term mortality and incidence of major adverse cardiovascular events. These individuals also experienced higher rates of long-term all-cause mortality and incidence of major adverse cardiovascular events.

BMC CARDIOVASCULAR DISORDERS (2023)

Article Cardiac & Cardiovascular Systems

Novel GSDMD inhibitor GI-Y1 protects heart against pyroptosis and ischemia/reperfusion injury by blocking pyroptotic pore formation

Lingfeng Zhong, Jibo Han, Xiaoxi Fan, Zhouqing Huang, Lan Su, Xueli Cai, Shuang Lin, Xudong Chen, Weijian Huang, Shanshan Dai, Bozhi Ye

Summary: The study identified a new drug (GI-Y1) for treating cardiac disorders by targeting GSDMD, and discovered a new tool compound for pyroptosis research.

BASIC RESEARCH IN CARDIOLOGY (2023)

暂无数据